Mylan launches Efavirenz in USA, first generic version of BMS’s HIV type 1 treatment Sustiva
Mylan is launching Efavirenz Tablets USP, 600 mg, in the USA, the first generic version of Bristol-Myers Squibb’s Sustiva, which
Read more
Efavirenz
Cipla launching low-dose Efavirenz 400 mg HIV infection therapy
Cipla launching low-dose Efavirenz 400 mg HIV infection therapy
Read more